Independent forecasts built on public federal data. Not a U.S. government website.

6550--Blood Control Reagents

36C25625Q1470 · VETERANS AFFAIRS, DEPARTMENT OF

A IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING solicitation, performed in Shreveport, with responses due 2025-09-12. AwardCast estimates what this specific solicitation will close for, before you bid.

36C25625Q1470
solicitation
325413
NAICS
6550
PSC
Not set aside
set-aside
Shreveport
place
2025-09-12
responses due

What's being bought

RFQ 36C25625Q1470 Question and Answer Reponses The purpose of this amendment is to: Clarify that this requirement is LPTA for brand name or equal to products. Clarify that all CLIN 0001-4026 are all brand name or equal to products and the OEM for the CLINs listed is Werfen. Address the questions sub

Comparable recent awards in IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

WinnerAward valueOffersDate
REMEL INC.$64Kn/a2026-07-02
CEPHEID$306Kn/a2026-07-01
ABBOTT LABORATORIES INC.$102K12026-07-01
ROCHE DIAGNOSTICS CORPORATION$615K12026-07-01
ABBOTT LABORATORIES INC.$2.8Mn/a2026-07-01

Questions

What is solicitation 36C25625Q1470?

6550--Blood Control Reagents, issued by VETERANS AFFAIRS, DEPARTMENT OF, under NAICS 325413 (IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING), performed in Shreveport. Responses are due 2025-09-12.

What do similar contracts close for?

Comparable closed awards in this category ran from $64K to $2.8M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.

Explore the market

Comparable awards in this market ran from $64K to $2.8M. Get the full set by email.

Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.

Every forecast is scored against the real award once it becomes public. See the track record.

Closed awards from public federal data, not the forecast. One email, no account.

Or get the forecast for this solicitation — $49, one report.